Aspartic Acid 386 Negatively Regulates Nuclear Translocation of PTEN
Genes to Cells · 2026-11 · 31 (6)
DOI: 10.1111/gtc.70155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 09.11.2026. Verfasst von Takashi Kato und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Cell Nucleus, Aspartic Acid. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Yasuda Women's University Scientific Research Aid and by the Japan Society for the Promotion of Science (JSPS) KAKENHI, KAKENHI.
Abstract (Originalsprache)
Phosphatase and tensin homolog (PTEN) is a tumor suppressor that helps maintain genomic integrity, particularly through its nuclear functions. Although PTEN is distributed throughout the cell under normal conditions, it translocates to the nucleus following DNA damage. The Ser380/Thr382/Thr383/Ser385 (STTS) cluster is critical for subcellular localization; however, its detailed regulatory mechanisms remain unclear. In the present study, aspartic acid 386 (Asp386) was identified as a novel determinant of PTEN subcellular localization. PTEN fragmentation experiments indicated that residue 386 is critical for subcellular localization. The D386R (Asp386‐to‐Arg) variant exhibited nuclear accumulation comparable to that of the A4 (STTS‐to‐alanine) variant, and the double mutant exhibited a similar level of nuclear accumulation. Consistent with the requirement of Lys13 ubiquitination for nuclear import, the related double mutants PTEN K13R,A4 and PTEN K13R,D386R exhibited comparable plasma membrane localization, while the triple mutant PTEN K13R,A4,D386R also showed no significant difference in plasma membrane localization. Furthermore, western blot analysis revealed that the D386R mutation reduced Ser380/Thr382/Thr383 phosphorylation. These findings suggest that an acidic residue at position 386 is important for efficient phosphorylation of the STTS cluster and cytoplasmic retention of PTEN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan.
ORCID-Profile: Takashi Kato
Förderung
- Yasuda Women's University Scientific Research Aid and by the Japan Society for the Promotion of Science (JSPS) KAKENHI
- KAKENHI
Zitieren
APA
Kato, T., Ohtsuki, Y., Mitani, M., & Fujita, M. (2026). Aspartic Acid 386 Negatively Regulates Nuclear Translocation of PTEN. Genes to Cells, 31(6). https://doi.org/10.1111/gtc.70155
Vancouver
Kato T, Ohtsuki Y, Mitani M, Fujita M. Aspartic Acid 386 Negatively Regulates Nuclear Translocation of PTEN. Genes to Cells. 2026;31(6). doi:10.1111/gtc.70155
BibTeX
@article{Kato2026,
author = {Kato, Takashi and Ohtsuki, Yuya and Mitani, Moe and Fujita, Mai},
title = {Aspartic Acid 386 Negatively Regulates Nuclear Translocation of PTEN},
journal = {Genes to Cells},
year = {2026},
volume = {31},
number = {6},
doi = {10.1111/gtc.70155}
}
EUVIMED